Amplify Weight Loss Drug & Treatment ETF HKSE:01801 Holdings History
Amplify Weight Loss Drug & Treatment ETF's Innovent Biologics Inc Holding Summary
As of 2025-03-31, Amplify Weight Loss Drug & Treatment ETF held 30,500.00 shares of Innovent Biologics Inc(HKSE:01801), totaling HK$182,680.00. This investment constitutes 4.85% of their stock portfolio, and Amplify Weight Loss Drug & Treatment ETF now holds 0% of the outstanding Innovent Biologics Inc(HKSE:01801) stock.
The initial trade took place in 2024Q2. And since then Amplify Weight Loss Drug & Treatment ETF has made 3 purchases of HKSE:01801, at an average price of HK$38.77, for a total of 30,500.00 shares. Based on historical transaction data and HKSE:01801's current price of HK$82.35, Amplify Weight Loss Drug & Treatment ETF's estimated gain on his HKSE:01801 holdings is HK$1.33 Mil, reflecting a 112.42% gain to date.
Amplify Weight Loss Drug & Treatment ETF HKSE:01801 (HK$82.35) Holding Chart
Amplify Weight Loss Drug & Treatment ETF HKSE:01801 (HK$82.35) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price HK$-/Share | ||
| Shares Sold | 0 | Average Price HK$-/Share | ||
| Current Price HK$0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
